Companies: 49,246 Total Market Cap: 132386205533959.40

Sopharma AD

BUL-SFA
Pharmaceutical Preparations
Rank #12257
Market Cap 617.14 M
Volume 29
Price 3.71
Change (%) 0.62%
Country or region Bulgaria Bulgaria

Sopharma AD's latest marketcap:

617.14 M

As of 05/20/2025, Sopharma AD's market capitalization has reached $617.14 M. According to our data, Sopharma AD is the 12257th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 617.14 M
Revenue (ttm) 1.23 B
Net Income (ttm) 44.70 M
Shares Out 166.36 M
EPS (ttm) 0.27
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 04/30/2025
Market Cap Chart
Data Updated: 05/20/2025

Sopharma AD's yearly market capitalization.

Sopharma AD has seen its market value grow from 402.46 M BGN to 1.07 B BGN since 2020, representing a total increase of 167.03% and an annual compound growth rate (CAGR) of 25.09%.
Date Market Cap(BGN) Change (%)
05/20/2025 1.07 B 11.49%
12/27/2024 957.99 M 5.26%
12/29/2023 910.12 M 68.2%
12/29/2022 541.08 M -2.7%
12/30/2021 556.10 M 38.17%
12/30/2020 402.46 M

Company Profile

About Sopharma AD

Sopharma AD is a leading pharmaceutical company specializing in the production, distribution, and export of medical products across Europe, Bulgaria, and international markets. Founded in 1933 and headquartered in Sofia, Bulgaria, the company offers a diverse portfolio of healthcare solutions.

Key Products & Services

  • Pharmaceutical Products: Includes treatments such as Carsil (liver disease), Tempalgin (painkiller), Tabex (smoking cessation), and Tribestan (male reproductive health).
  • Medical Devices: Supplies gauzes, compresses, dressings, and other essential healthcare materials.
  • Food Supplements & Cosmetics: Offers herbal cosmetics, vitamins, and sanitary-hygiene products.
  • Prescription & OTC Medicines: Provides both prescription drugs and over-the-counter medications, including veterinary products.
  • Contract Manufacturing: Delivers packaging, product development, and manufacturing services.
  • Distribution & Retail: Engages in wholesale and retail trade of pharmaceuticals, medical equipment, and cosmetics.

Additional Business Activities

Sopharma AD also operates in:

  • Trading of radioactive materials for medicinal use.
  • Production and trade of herbs and medicinal plants.
  • Public opinion research and consulting services.
  • Franchising, property rental, and online/offline retail.
Frequently Asked Questions

As of 05/20/2025, Sopharma AD (including the parent company, if applicable) has an estimated market capitalization of $617.14 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Sopharma AD global market capitalization ranking is approximately 12257 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Bulgaria
Founded 1933
IPO Date n/a
Employees 5,599
CEO Ognian Donev
Sector
Industry Pharmaceutical Preparations
Address 16, Iliensko Shousse St.
Sofia, 1220
Bulgaria
Website https://www.sopharmagroup.com
People Also Watch
Ipsen S.A.
138.21 0.62%
Krka, d. d.
209.75 0.62%
BUD-RICHTER
29.11 0.62%
Hugel
244.93 0.62%